StonvexLoading…
StonvexStonvexStonvexCore line items from CLPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $12.13M | $36.97M | $26.56M | $17.70M |
Operating Income | $-8.48M | $-24.16M | $-17.12M | $-11.84M |
Net Income | $-9.55M | $-25.54M | $-17.75M | $-5.84M |
EPS (Diluted) | $-0.32 | $-0.90 | $-0.63 | $-0.42 |
Total Assets | $93.42M | $97.75M | $60.36M | $62.87M |
Total Liabilities | $74.58M | $69.73M | $44.48M | $43.13M |
Cash & Equivalents | $35.59M | $45.92M | $38.22M | $41.54M |
Free Cash Flow OCF − CapEx | $-8.61M | $-24.42M | $-12.32M | $-9.00M |
Shares Outstanding | 29.99M | 29.37M | 28.43M | 28.42M |